Avantor, Inc. (AVTR)

NYQ – Real Time Price. Currency in USD

10.28

+0.20 (1.98%)

At close: Jun 26, 2026, 4:00 PM EDT

10.28

0.00 (0.00%)

After-hours: Jun 26, 2026, 5:05 PM EDT

29.05.2026

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

29.05.2026

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

19.05.2026

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.

07.05.2026

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.

30.04.2026

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.

30.04.2026

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.

29.04.2026

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
AVTR	Raymond James	Market Perform	undefined >> undefined	November 4th 2025
AVTR	Barclays	Equal Weight	undefined >> $12	October 30th 2025
AVTR	JP Morgan	Neutral	undefined >> $12	October 30th 2025
AVTR	Jefferies	Hold	undefined >> undefined	August 1st 2025
AVTR	Goldman	Neutral	undefined >> $14	April 29th 2025
AVTR	TD Cowen	Hold	undefined >> $16	April 28th 2025
AVTR	Stifel	Hold	undefined >> $14	April 28th 2025
AVTR	Morgan Stanley	Equal Weight	undefined >> undefined	April 28th 2025

Press releases

19.05.2026

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

29.04.2026

Avantor® Reports First Quarter 2026 Results

Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.

23.04.2026

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

RADNOR, Pa., April 23, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Ludovic Brellier will join the company as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer on May 1, 2026.

22.04.2026

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE: AVTR) breached their fiduciary duties to shareholders.

Avantor, Inc. (AVTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Avantor, Inc. (AVTR)

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Search stocks

Avantor, Inc. (AVTR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Avantor, Inc. (AVTR)

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Videos

No Data

Upgrades / Downgrades

Press releases

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm